The stem cell controversy is the bioethical debate primarily concerning the creation, treatment, and destruction of human embryos incident to research involving embryonic stem cells. Not all stem cell research involves the creation, use, or destruction of human embryos. For example, adult stem cells, amniotic stem cells and induced pluripotent stem cells do not involve human embryos.
Stem cells have the ability to differentiate into almost any specialized cells, helping heal physical trauma, degenerative conditions, and genetic diseases (in combination with gene therapy). Further treatments using stem cells could potentially be developed thanks to their ability to repair extensive tissue damage.[1]
Great levels of success and potential have been shown from research using adult stem cells. In early 2009, the FDA approved the first human clinical trials using embryonic stem cells. Embryonic stem cells are pluripotent, and thus can become any other cell type excluding the placenta. Adult stem cells, however, are generally limited to differentiating into different cell types of their tissue of origin. However, some evidence suggests that adult stem cell plasticity may exist, increasing the number of cell types a given adult stem cell can become. In addition, embryonic stem cells are considered more useful for nervous system therapies, because researchers have struggled to identify and isolate neural progenitors from adult tissues. Embryonic stem cells, however, might be rejected by the immune system - a problem that wouldn't occur if the patient received his or her own stem cells.
Some stem cell researchers are working to develop techniques of isolating stem cells that are as potent as embryonic stem cells, but do not require a human embryo.
Some believe that human skin cells can be coaxed to "de-differentiate" and revert to an embryonic state. Researchers at Harvard University, led by Kevin Eggan, have attempted to transfer the nucleus of a somatic cell into an existing embryonic stem cell, thus creating a new stem cell line.[2] Another study published in August 2006 also indicates that differentiated cells can be reprogrammed to an embryonic-like state by introducing four specific factors, resulting in induced pluripotent stem cells.[3] Human skins cells reverting to their embryonic state have been accomplished at the Oregon Health & Science University and the Oregon National Primate Research Center, making this no longer a matter of belief.[4]
Researchers at Advanced Cell Technology, led by Robert Lanza, reported the successful derivation of a stem cell line using a process similar to preimplantation genetic diagnosis, in which a single blastomere is extracted from a blastocyst.[5] At the 2007 meeting of the International Society for Stem Cell Research (ISSCR),[6] Lanza announced that his team had succeeded in producing three new stem cell lines without destroying the parent embryos. "These are the first human embryonic cell lines in existence that didn't result from the destruction of an embryo." Lanza is currently in discussions with the National Institutes of Health (NIH) to determine whether the new technique sidesteps U.S. restrictions on federal funding for ES cell research.[7]
Anthony Atala of Wake Forest University says that the fluid surrounding the fetus has been found to contain stem cells that, when utilized correctly, "can be differentiated towards cell types such as fat, bone, muscle, blood vessel, nerve and liver cells". The extraction of this fluid is not thought to harm the fetus in any way. He hopes "that these cells will provide a valuable resource for tissue repair and for engineered organs as well".[8]
While stem cell research has, for years, been stymied by concerns of ethics and morals, in recent years there have been advances in obtaining and using stem cells extracted from adult subjects. By using stem cells taken from an adult, scientists have been able to treat some of the worst diseases that continue to plague our species, including various forms of cancer as well as muscular and neurological degenerative diseases. Taking these stem cells from adults does not permanently harm the patient and has none of the ethical or moral pitfalls that embryonic stem cell research has been associated with. While this new form of stem cell research is gaining in popularity, it still has a stigma attached to it solely by being stem cell research. If the public can be educated about this, a new form of medicine may be fast approaching from the horizon.
The status of the human embryo and human embryonic stem cell research is a controversial issue as, with the present state of technology, the creation of a human embryonic stem cell line requires the destruction of a human embryo. Stem cell debates have motivated and reinvigorated the pro-life movement, whose members are concerned with the rights and status of the embryo as an early-aged human life. They believe that embryonic stem cell research instrumentalizes and violates the sanctity of life, and some also view it as tantamount to murder.[9] The fundamental assertion of those who oppose embryonic stem cell research is the belief that human life is inviolable, combined with the belief that human life begins when a sperm cell fertilizes an egg cell to form a single cell.
A portion of stem cell researchers use embryos that were created but not used in in vitro fertility treatments to derive new stem cell lines. Most of these embryos are to be destroyed, or stored for long periods of time, long past their viable storage life. In the United States alone, there have been estimates of at least 400,000 such embryos.[10] See also Embryo donation.
Read more:
Stem cell controversy - Wikipedia, the free encyclopedia
- NIH Guidelines for Human Stem Cell Research | STEM Cell ... - January 2nd, 2022
- LifeBank Chain Announces Upcoming Gene and Cell Collaboration Platform With Disrupt Blockchain Technologies - Yahoo Finance - January 2nd, 2022
- Global Automated and Closed Cell Therapy Processing Systems Market By type, By workflow, By scale, By Regional Outlook, Industry Analysis Report and... - January 2nd, 2022
- The Worldwide Culture Media Industry is Expected to Reach $13+ Billion by 2030 - GlobeNewswire - January 2nd, 2022
- Global Single-Use Bioreactors Market by Product, Molecule, Cell type, Application, End-user, and Region - Forecast to 2026 - Yahoo Finance UK - January 2nd, 2022
- With soaring demand for meat, it's time to fund animal-free protein research | TheHill - The Hill - January 2nd, 2022
- Stem Cell Artificial Meat Market Size 2021 Analysis by Top Companies, And Forecast to 2028 | Beyond Meat,Impossible Foods,Memphis Meats,Boca Foods ... - January 2nd, 2022
- Cell Separation Technology Market Size, Analysis, Forecast to 2028 | Key Players Akadeum Life Sciences, STEMCELL Technologies, BD, Bio-Rad... - January 2nd, 2022
- Best Scientific Discoveries and Breakthroughs of 2021 - Newsweek - January 2nd, 2022
- Research Report on Liver Cirrhosis Market Size 2021-2026 Industry Share and Demand Analysis of Key Players Industrial IT - Industrial IT - January 2nd, 2022
- Cell Expansion Market Size, Analysis, Forecast to 2029 | Key Players Thermo Fisher Scientific GE Healthcare (A Wholly Owned Subsidiary of General... - January 2nd, 2022
- Cell Counting Market Outlook 2021 Growth Drivers, Opportunities and Forecast Analysis To 2028 Industrial IT - Industrial IT - January 2nd, 2022
- The most searched songs on Google in 2021 - Market Research Telecast - December 9th, 2021
- The Architecture of the Human Fovea Webvision - November 8th, 2021
- The Role of Reproductive Hormones in Postpartum Depression - November 8th, 2021
- 'Limb vs. Tail' lecture articulates variations of axolotl regeneration during research development The Maine Campus - The Maine Campus - November 8th, 2021
- Century Therapeutics to Present at the 63rd American Society of Hematology Annual Meeting and Host Virtual Research & Development Update -... - November 8th, 2021
- Clade Therapeutics Raises $87 Million Series A Financing to - GlobeNewswire - November 8th, 2021
- Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent ... - The Bakersfield Californian - November 8th, 2021
- NextCure Reports Third Quarter 2021 Financial Results and Provides Business Update - Yahoo Finance - November 8th, 2021
- Bristol Myers Squibb to Highlight More than 80 Abstracts at ASH 2021 Demonstrating Strength of Innovative Therapeutic Platforms Improving Outcomes for... - November 8th, 2021
- Atara Biotherapeutics to Present Eight Abstracts at the 63rd American Society of Hematology (ASH) Annual Meeting, Including First Presentation of... - November 8th, 2021
- CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results - GlobeNewswire - November 8th, 2021
- UVA Science and Engineering Faculty Win 12 NSF Career Awards - University of Virginia - November 8th, 2021
- MAGENTA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - marketscreener.com - November 8th, 2021
- Ronawk using stem cell tech developed at Olathe lab to advance liver cancer research in Turkey - Startland News - October 5th, 2021
- StemExpress Partners with the Alliance for Regenerative Medicine to Provide COVID-19 Testing for the Cell and Gene Meeting on the Mesa - WSAW - October 5th, 2021
- Researching the Safety and Effectiveness of Stem Cells to Treat 'Long Covid' - Entrepreneur - October 5th, 2021
- Global Hemoglobinopathies Markets, 2021-2028 - High Unmet Needs / Increasing R&D; Investment / Initiatives to Improve Disease Awareness -... - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - KY3 - October 5th, 2021
- Stanford neuroscientist's 'assembloids' pave the way for innovative brain research - Scope - October 5th, 2021
- Exosome therapeutic Market 2021 is Showing Impressive Growth by 2028 | Trends, Share, Size, Top Key Players Analysis and Forecast Research EcoChunk -... - October 5th, 2021
- BrainStorm to Present at the 2021 Cell & Gene Meeting on the Mesa - WWNY - October 5th, 2021
- Cell Based Assay & High Content Screening Market Report 2021: The Workhorse of the Pharmaceutical Industry is Becoming a Central Player in... - October 5th, 2021
- Advancing the Development of Innovative Veterinary Products - FDA.gov - October 5th, 2021
- Pharmaxis Cleared To Progress To Phase 2 Bone Marrow Cancer Trial - WBKO - October 5th, 2021
- $500K Grant Supports Research on Muscle Growth in Pigs, With Broader Health Implications - Maryland Today - July 22nd, 2021
- EU approves bluebird bio's CALD gene therapy Skysona - PMLiVE - July 22nd, 2021
- Secrets and pies: the battle to get lab-grown meat on the menu - The Guardian - July 22nd, 2021
- Biomedical Warming and Thawing Devices Market Revenue to Cross USD 308 Mn by 2027: Global Market Insights Inc. - Markets Insider - July 22nd, 2021
- A Recovery for All Of Us: New York City Invests $1 Billion in Life Sciences - Brooklyn Daily Eagle - July 22nd, 2021
- The growing global "infodemic" around stem cell therapies - Axios - June 25th, 2021
- NanoString Launches nCounter Stem Cell Characterization Panel to Advance the Development of Stem Cell Therapy - Yahoo Finance - June 25th, 2021
- Catalent to Acquire RheinCell Therapeutics, Strengthening a Path Towards Industrialization of Induced Pluripotent Stem Cell-based Therapies - Yahoo... - June 25th, 2021
- Immusoft Announces Formation of Scientific Advisory Board - Business Wire - June 25th, 2021
- Jasper Therapeutics and Aruvant Announce Research Collaboration to Study JSP191, an Antibody-Based Conditioning Agent, with ARU-1801, a Novel Gene... - June 25th, 2021
- Gamida Cell Announces Publication in Blood, the Journal of the American Society of Hematology, of the First Pivotal Trial to Evaluate a Cell Therapy... - June 25th, 2021
- More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities - PRNewswire - June 25th, 2021
- Andrs Garca Receives Distinguished Professor Award | Research - Research Horizons - June 25th, 2021
- Local foundation awards $1.25 million to MIND Institute to study rare genetic condition - UC Davis Health - June 25th, 2021
- MeCP2 is a microsatellite binding protein that protects CA repeats from nucleosome invasion - Science Magazine - June 25th, 2021
- The Stem Cell Manufacturing market is projected to reach USD 18.0 billion by 2026 from USD - GlobeNewswire - May 28th, 2021
- Jasper Therapeutics Announces New Clinical Trial with the National Institute of Allergy and Infectious Diseases to Evaluate JSP191 in Chronic... - May 28th, 2021
- Global Flow Cytometry Market (2020 to 2026) - by Technology, Product and Service, Application, End-user and Geography - ResearchAndMarkets.com -... - May 28th, 2021
- Meso-Brain project explores 3D printed stem cells to treat neurological conditions - 3D Printing Industry - May 28th, 2021
- Moderna Highlights Advances in Platform Science and Innovative Vaccine Research at Fourth Annual Science Day - Business Wire - May 28th, 2021
- GPB Scientific Announces Additional Growth Financing to Support Commercialization of Curate Cell Processing System for Next-Generation Cell & Gene... - May 28th, 2021
- TScan Therapeutics Adds to Executive Leadership Team and Board of Directors - BioSpace - May 28th, 2021
- Bone Therapeutics Provides First Quarter 2021 Business Update - GlobeNewswire - May 28th, 2021
- Merakris Therapeutics, Inc. Announces FDA Clearance for - GlobeNewswire - May 28th, 2021
- Stem Cell Manufacturing Market 2021 | Research With Size, Growth, Manufacturers, Key Segment, Analysis, Development Status, Segments and 2027... - February 19th, 2021
- Tissue regeneration: Reserve or reverse? - Science Magazine - February 19th, 2021
- Global Scaffold Technology Market Is Expected to Reach USD 2.16 billion by 2028 : Fior Markets - GlobeNewswire - February 19th, 2021
- Recombinant Growth Factors to Account for Over 45% of Overall Demand through 2031: Persistence Market Research - PRNewswire - February 19th, 2021
- The Untapped Potential of Cell and Gene Therapy - AJMC.com Managed Markets Network - February 19th, 2021
- Century Therapeutics Significantly Expands Capabilities with New Operational, Laboratory and Manufacturing Facilities in Pennsylvania and New Jersey -... - February 19th, 2021
- Cell Therapy Processing Market To Grow Value $12062 Million By 2026 | Latest Research Report - PharmiWeb.com - February 19th, 2021
- Global Stem Cell Therapy Market 2020 | Demand and Scope with Outlook, Business Strategies, Challenges and Forecasts to 2025 KSU | The Sentinel... - February 19th, 2021
- Humanized Mouse and Rat Model Market: Increased development of monoclonal antibodies and improved healthcare to drive the market - BioSpace - February 19th, 2021
- Iterion Therapeutics Secures $17 Million to Advance Development of Tegavivint in Multiple Tumor Settings - PRNewswire - February 19th, 2021
- Global Apoptosis Assays Market Estimated To Expand At A Robust CAGR By 2027||Promega, Abcam plc, Research And Diagnostic Systems, Inc., Sartorius AG,... - February 19th, 2021
- Tibidabo Scientific Industries Strengthens its Core Executive Team with the Appointment of Industry Veteran, John LaViola as Chief Technology Officer... - February 19th, 2021
- Global Cell Expansion Market Value Projected to Expand by 2021-2026 | Thermo Fisher Scientific, Inc., GE Healthcare, Lonza Group Ltd., Becton,... - February 19th, 2021
- How Irish medtech came to thrive - Med-Tech Innovation - February 19th, 2021
- Translational Regenerative Medicine Market: Immunotherapy is projected to be the fastest growing segment during the forecast period - BioSpace - February 11th, 2021
- Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First Off-the-shelf Genomic Medicines - Business Wire - February 11th, 2021
- Notch Therapeutics Closes $85 Million Series A Financing to Develop Pipeline of Renewable Stem Cell-Derived Cancer Immunotherapies - PRNewswire - February 11th, 2021
- Global Biopreservation Market Is Expected to Reach USD 7.67 Billion by 2028 : Fior Markets - GlobeNewswire - February 11th, 2021
- Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater... - February 11th, 2021
- Stem Cell Therapy Market Revenue, Key Players, Supply-Demand, Investment Feasibility and Forecast By 2029: Osiris Therapeutics, NuVasive, Chiesi... - February 11th, 2021
